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Background: There are few tools to detect the diabetic autonomic neuropathy at an earlier stage. This study was conducted 
to investigate the association between symptoms of autonomic neuropathy and the heart rate variability (HRV) in 
diabetics. 
Methods: Study subjects consisted of 50 diabetic patients and 30 outpatient hospital control patients at a university family 
medicine department. The patients completed a Korean version of composite autonomic symptom scale (COMPASS). 
Electrocardiography was recorded in the supine position, on standing, and during deep breathing, for 5 minutes each. 
HRV of frequency domain was calculated by power spectral analysis. 
Results: The COMPASS score was higher in female diabetic patients compared with that in controls. Among 50 diabetic 
patients, the total COMPASS score correlated positively with normalized low frequency (LF) score (normalized units, n.u.) 
(r = 0.62, P < 0 .001) and low frequency/high frequency (LF/HF) (r = 0.77, P < 0.001), negatively with normalized HF score 
(n.u.) (r = -0.59, P < 0.001) and RMSSD (square root of the mean of the sum of the square of differences between adjacent 
NN interval; r = -0.33, P = 0.031). The decrease in LF (n.u) and the increase in HF (n.u) by deep breathing from the supine 
position were higher in diabetic patients compared with those in controls. The increase in LF (n.u) and the decrease in 
HF (n.u) by standing from the supine position were lower in diabetic patients compared with those in controls.
Conclusion: The COMPASS score correlated with some component score of the HRV in diabetics. The HRV may be used as 
a tool to detect diabetic autonomic neuropathy by augmentation with position change.
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INTRODUCTION
Diabetic autonomic neuropathy may occur at any stage of 
diabetes, but it usually develops in patients who have had diabetes 
for 20 years or more.
1) Cardiovascular autonomic neuropathy may 
result in orthostatic hypotension, persistent sinus tachycardia, 
and asymptomatic myocardial infarction
2) which may predispose 
sudden death.
3-5) 
Therefore careful history taking and a thorough physical 
examination are important to screen the presence of diabetic Min-Young Chun, et al: The Association between Symptoms of Autonomic Neuropathy and the Heart Rate Variability in Diabetics
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METHODS
1. Subjects
Study subjects consisted of 50 diabetic patients (34 male, 16 
female) and 30 outpatient hospital control patients (11 male, 19 
female) at a university family medicine department from March 
2008 through August 2008. Age of the study subjects ranged 
from 42 to 74 years old. Diagnosis and classifi  cation of diabetes 
were based on guidelines of the Expert Committ  ee Report of the 
American Diabetes Association.
13) 
We excluded those with known arrhythmia, unstable angina, 
myocardial infarction, or cerebrovascular disease, and those who 
were taking any autonomic drug such as β-blocker, β-agonist, 
calcium channel blocker, or angiotensin-converting enzyme 
inhibitors, etc. The written consent was obtained from each 
patient before enrollment in the study. Th   is study was approved 
by the Institutional Review Board of Hanyang University Hos-
pital, in Seoul, Korea. As baseline clinical characteristics, patient's 
age, sex, body mass index, smoking status, alcohol intake, exercise, 
and average consumption of coffee were assessed. Systolic 
and diastolic blood pressures were measured by a mercury 
sphygmomanometer. Th   e serum levels of fasting blood glucose, 
total cholesterol, triglyceride, high density lipoprotein cholesterol, 
low density lipoprotein cholesterol were measured by standard 
methods. 
2. Measurement of Autonomic Symptoms and 
the HRV
1) COMPASS 
The COMPASS has weighted 9 subscale scores that assess 
severity of symptoms in the following domains: orthostatic 
intolerance (9 items; range, 0 to 40), secretomotor dysfunction (8 
items; range, 0 to 20), male sexual dysfunction(8 items; range, 0 to 
30), bladder dysfunction (3 items; range, 0 to 20), gastrointestinal 
symptoms (14 items; range, 0 to 40), pupillomotor symptoms 
(7 items; range, 0 to 5), vasomotor symptoms (11 items; range, 
0 to 10), reflex syncope (5 items; range, 0 to 20), and sleep 
dysfunction (8 items; range, 0 to 15). Th   e range of item score is 
from the minimum score of two to the maximum score of seven 
in each item. The total scores are calculated by summation of 
the individual item scores and the maximum score may be up 
neuropathy at an early stage of diabetes. Diagnosis of diabetic 
autonomic neuropathy primarily depends on several autonomic 
symptoms, but few studies validated symptom profile as a 
diagnostic tool.
6,7) 
The heart rate variability (HRV) is a physiological pheno-
menon which refl  ects the variety of time intervals between heart 
beats. It is measured by the variation in the beat-to-beat interval. 
The main inputs to make a HRV are the balance between the 
sympathetic nervous system (SNS) and the parasympathetic 
nervous system (PNS). By detecting HRV, we can compare the 
relative activity of the SNS with the PNS. Th   e HRV is also used to 
evaluate the cardiovascular autonomic regulation.
8) 
Power spectral analysis demonstrates the HRV as a time 
domain and a frequency domain. As a time domain, RMSSD 
(square root of the mean of the sum of the square of diff  erences 
between adjacent NN interval) reflects the parasympathetic 
activity. As a frequency domain, high frequency (HF) activity 
(0.4 to 0.15 Hz), especially, has been linked to PNS activity. Less 
is known about the physiological inputs of the low frequency 
(LF) activity (0.04 to 0.15 Hz), though recent consensus suggests 
it is infl  uenced either by the SNS or a mixture of both the SNS 
and the PNS. Th   e LF/HF ratio is known to be infl  uenced by the 
sympathovagal balance.
9,10) 
Th   e composite autonomic symptom scale (COMPASS) is a 
self-completed questionnaire that is composed of 73 items. Th  ese 
questions are important and critical in the diagnosis of autonomic 
neuropathy.
11) The COMPASS has nine weighted subscale 
scores and total score is calculated by summing the individual 
subscale score. It has been proved to correlate objective indexes 
of autonomic function and autonomic symptom severity.
12) Th  e 
HRV as a tool to measure autonomic balance may be related with 
the COMPASS symptom profi  le, but there was no study about 
it. If we know the association between these two measurements, 
we can use them complementary to each other because one is 
symptom-based, and the other is autonomic sign-based.  
This study was conducted to investigate the association 
between symptoms of autonomic neuropathy and the HRV in 
diabetics. Min-Young Chun, et al: The Association between Symptoms of Autonomic Neuropathy and the Heart Rate Variability in Diabetics
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by Analog to Digital Converter (MP150, BIOPAC Systems Inc., 
Goleta, CA, USA) and analyzed by the program of HRV Analysis 
ver. 1.1 (Department of Applied Physics, University of Kuopio, 
Eastern Finland, Finland). We calculated mean RR, RMSSD as 
a time domain, LF (0.04-0.15 Hz), HF (0.15-0.4 Hz), LF/HF 
ratio as a frequency domain by power spectral analysis. The LF 
and HF power were transformed into normalized units (n.u.). 
Transforming data into normalized units also helped to accentuate 
sympathovagal balance. Normalized units were calculated as 
follows: LF (n.u.) = LF power / TP-VLF power × 100; HF (n.u.) 
= HF power / TP-VLF power × 100 (TP, total power; VLF, very 
low frequency).
3. Statistical Analysis
All clinical data were summarized as median and interquartile 
range. Continuous clinical data were compared between diabetic 
patients and controls by using Mann-Whitney U test, Student's 
t-test. Partial correlation coefficient, Pearson r was calculated 
to examine the correlation between the total COMPASS score 
and HRV domain scores after adjusting confounding variables. 
We used SPSS ver. 15.0 (SPSS Inc., Chicago, IL, USA). We 
to 200 (in man) or 170 (in woman). All subjects completed the 
questionnaire within 5 minutes. 
2) HRV  
Study subjects got the blood test at fasting state for 8 hours, 
avoiding alcoholic drink, caff  eine beverage, and excessive exercise 
for 24 hours before the test. The measurement was done from 
9:00 AM to noon at room temperature of 22-24
oC in a quiet 
and comfortable environment. Participants took a rest for three 
minutes or more in the supine position and were oriented on 
the method of the test. Electrocardiography was recorded in 
the supine position, on standing, and during deep breathing 
(inspiration for 3 seconds and expiration for 3 seconds), for 5 
minute each. The HRV of frequency domain was calculated by 
power spectral analysis. 
3) HRV data analysis
Th   e MATLAB ver. 7.04 (Mathwork Inc., Natick, MA, USA) 
reorganized the electrocardiography of each participant, then we 
deleted the abnormal heart beat and any artifact by using hand 
operated manual. Data of electrocardiography were digitalized 
Table 1. Baseline demographic characteristics of study subjects. 
Characteristics
Male Female
Diabetics (n = 34) Non-diabetics (n = 11)  Diabetics (n = 16) Non-diabetics (n = 19) 
Age (y)    52 (48-66)    53 (45-63)    61 (50-65)    60 (53-65)
Duration (y)   7.0 (3-10) NA    6.5 (3-10) NA 
BMI (kg/m
2) 25.5  (25.0-26.8) 25.3 (23.0-26.2) 26.0 (24.5-28.1) 25.5 (24.9-26.1)
Smoking (pack ∙ y)      0 (0-20)    20 (0-30)      0 (0-0)      0 (0-0)
Coffee (cups/d)      2 (1-3)      2 (0-4)      1 (0-2)      0 (0-2)
Exercise (h/d)      1 (0-1)      1 (0-2)      1 (0-1)      1 (0-1)
Systolic BP (mm Hg)  126 (112-140)  125 (110-140)  128 (114-142)  120 (120-140)
Diastolic BP (mm Hg)    80 (78-82)    80 (78-80)    80 (78-82)    80 (80-80)
Fasting blood sugar (mg/dL)   126 (106-145)*  103 (97-110)  124 (113-135)*    98 (95-102)
HDL-C (mg/dL)     41 (35-47)    50 (41-57)     49 (44-54)    48 (45-55)
LDL-C (mg/dL)  100 (82-115)  110 (100-149)  104 (91-125)  111 (104-124)
Triglyceride (mg/dL)   116 (90-179)  122 (69-203)  115 (102-140)
†    95 (80-120)
Values are presented as median (interquartile range, 25-75‰).
BMI: body mass index calculated as weight in kilograms divided by height in meter squared, BP: blood pressure, HDL-C: high density 
lipoprotein cholesterol, LDL-C: low density lipoprotein cholesterol, NA: not available. 
*P <0.001. 
†P < 0.05 vs. non-diabetics by Mann-Whitney U-test.Min-Young Chun, et al: The Association between Symptoms of Autonomic Neuropathy and the Heart Rate Variability in Diabetics
Vol. 32, No. 5 Jul 2011  |  295 Korean J Fam Med
considered it statistically signifi  cant if P-values were below 0.05.
RESULTS
1. General Characteristics of the Study Sub-
jects 
Diabetic patients had higher fasting glucose (P < 0.001) both 
in men and in women group, low serum triglyceride (P < 0.05) in 
women when compared with those of controls. All other clinical 
characteristics were not signifi  cantly diff  erent between diabetics 
and control group (Table 1). 
2. The COMPASS Score
As a severity index of autonomic dysfunction, the total 
COMPASS score was higher in diabetic patients compared with 
that in controls. However, only female patients had signifi  cantly 
higher total COMPASS scores compared with the male controls 
(diabetics, 9.0; controls, 4.5; P < 0.05) (Table 2). Although data 
are not shown, among nine subscales, the subscale score of sleep 
Table 2. The comparison of COMPASS score and HRV domain scores between diabetics and non-diabetics. 
Variables
Male Female
Diabetics (n = 34) Non-diabetics (n = 11) Diabetics (n = 16) Non-diabetics (n = 19)
Total COMPASS scores 12.5 (8.0-16.0)   6.5 (1.5-22.5)   9.0 (3-15)*   4.5 (2-14)
Supine
LF (ms
2) 71.0  (28-155) 200.0 (21-304) 52.5 (16-117) 56.0 (46-107)
LF (n.u.)  71.9 (52-83) 61.1 (39-88) 55.6 (37-81) 60.3 (28-72)
HF (ms
2) 33.0  (16-56) 49.0 (17-204) 28.5 (11-103) 39.0 (29-117)
HF (n.u.) 28.2 (17-39) 38.9 (12-46) 44.4 (19-63) 39.7 (28-72)
LF/HF    2.6 (1.6-4.9)   1.6 (0.6-7.5)   1.3 (0.6-4.5)   1.5 (0.6-2.5)
RMSSD (ms) 19.5 (14.0-28.9) 23.7 (16.2-48.3) 16.7 (10.6-35.7) 24.7 (17.8-29.4)
Deep breathing
LF (ms
2) 36.0  (20-72) 51.0 (23-203) 25.5 (12-55) 46.0 (28-104)
LF (n.u.)  29.9 (22-40) 21.1 (16-56) 23.9 (16-38) 27.6 (17-35)
HF (ms
2) 84.0  (27-240) 121.0 (35-209) 100.0 (31-181) 162.0 (44-272)
HF (n.u.) 70.2 (60-78) 78.9 (44-84) 76.1 (62-84) 72.4 (65-83)
LF/HF    0.4 (0.3-0.7)    0.3 (0.2-1.3)   0.3 (0.2-0.6)   0.4 (0.2-0.6)
RMSSD (ms) 19.4 (15.4-31.9) 25.3 (16.4-41.9) 19.8 (10.4-31.6) 25.1 (17.1-40.0)
Standing
LF (ms
2) 73.5  (42-140) 58.4 (19-259) 41.5 (27-56) 58.0 (32-84)
LF (n.u.)  82.5 (72-85) 71.1 (63-85) 64.7 (37-75) 74.4 (62-82)
HF (ms
2) 16.5  (13-30) 23.7 (9-72) 23.5 (7-81) 26.0 (9-50)
HF (n.u.) 17.6 (15-28) 28.9 (15-37) 35.6 (25-63) 25.6 (18-38)
LF/HF    4.7 (2.7-6.3)   4.5 (1.6-5.9)   1.9 (0.5-3.2)   3.1 (1.5-4.5)
RMSSD (ms) 18.2 (12.6-25.2) 12.1 (9.3-23.1) 19.6 (10.6-23.7) 16.3 (9.9-20.2)
Values are presented as median (interquartile range, 25-75‰).
COMPASS: composite autonomic symptom scale, LF: low frequency power (0.004-0.15 Hz), n.u.: normalized units, HF: high frequency 
power (0.15-0.40 Hz), LF/HF: the ratio of low to high frequency power, RMSSD: square root of the mean of the sum of the square of 
differences between adjacent NN interval.
*P-value < 0.05 was obtained by Mann-Whitney U test vs. non-diabetics. Min-Young Chun, et al: The Association between Symptoms of Autonomic Neuropathy and the Heart Rate Variability in Diabetics
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5. Difference between HRV Domain Scores in 
Supine Position, in Supine Position with 
Deep Breathing, and on Standing 
In order to compare HRV responses to deep breathing and 
standing in two groups, we measured the difference between 
HRV domain scores in the supine position, in the supine position 
with deep breathing, and on standing (Table 4). Th   e decrease in 
LF (n.u) (P = 0.04) and the increase in HF (n.u) (P = 0.04) by 
deep breathing from the supine position were higher in diabetic 
patients compared with those in controls. The increase in LF 
(n.u) (P = 0.04) and the decrease in HF (n.u) (P = 0.03) by 
standing from the supine position were lower in diabetic patients 
compared with those in controls. 
DISCUSSION
Diabetic autonomic symptoms and signs manifest themselves 
definitely in pupil, sweat gland, urinary system, gastrointestinal 
system, adrenal system, and cardiovascular system. Antagonism 
and balance between sympathetic nerve and parasympathetic 
nerve effect on these systems.
14) The COMPASS is designed 
to provide a severity index of autonomic symptoms and gives 
different weights according to clinical importance. It yields one 
total score refl  ecting overall severity of autonomic symptoms.
15) 
In this study, we found that autonomic symptoms among 
dysfunction was significantly higher only in female diabetics 
compared with that of female control group (1.5 [range, 1 to 3] 
vs. 0 [range, 0 to 2]; P < 0.05). 
3. HRV Domain Scores
In order to examine the characteristics of HRV domains (LF 
[ms
2], LF [n.u.], HF [ms
2], HF [n.u.], LF/HF, RMSSD [ms]) of 
diabetic patients, HRV domain scores in diabetic patients were 
compared with those of controls. All HRV domain scores were 
not signifi  cantly diff  erent between these two groups in the supine 
position, on standing, and during deep breathing (Table 2).
4. The Correlation between COMPASS Scores 
and Each of HRV Domain Scores 
Partial correlation coeffi   cient between total COMPASS score 
and HRV domain score was calculated aft  er adjusting for age, sex, 
fasting blood glucose, body mass index, systolic blood pressure, 
diastolic blood pressure, smoking, high-density lipoprotein 
cholesterol, low-density lipoprotein cholesterol, and triglyceride. 
Among 50 diabetic patients, the total COMPASS score correlated 
positively with normalized LF score (n.u.) (r = 0.62, P < 0.001) 
and LF/HF (r = 0.77, P < 0.001), negatively with normalized HF 
score (n.u.) (r = -0.59, P < 0.001) and RMSSD (r = -0.33, P = 
0.031) (Table 3). 
Table 3. The correlation between the composite autonomic symptom scale (COMPASS) scores and each of heart rate variability domain 
scores at three positions in 50 diabetic patients.
Variables
Supine With breathing control Standing
r* P-value r* P-value r* P-value
LF    0.125    0.429 -0.023 0.887    0.102    0.519
HF -0.333    0.031 -0.077 0.628 -0.382    0.013
LF (n.u.)    0.621 <0.001    0.296 0.057    0.515    0.001
HF (n.u.) -0.589 <0.001 -0.278 0.075 -0.518 <0.001
LF/HF     0.768 <0.001    0.434 0.004    0.578 <0.001
RMSSD (ms) -0.334    0.031 -0.175 0.269 -0.274    0.079
LF: low frequency, HF: high frequency, RMSSD: square root of the mean of the sum of the square of differences between adjacent NN 
interval.
*Partial correlation coefﬁ  cient r was adjusted by age, sex, fasting blood glucose, body mass index, systolic blood pressure, diastolic blood 
pressure, smoking, high density lipoprotein cholesterol, low density lipoprotein cholesterol, and triglyceride.Min-Young Chun, et al: The Association between Symptoms of Autonomic Neuropathy and the Heart Rate Variability in Diabetics
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the independent prognostic factor of hypertensive ventricular 
hypertrophy, morbidity and mortality of cardiovascular diseases.
17-19)
Enabling risk stratification by screening for cardiac autonomic 
diabetic neuropathy (CADN) might facilitate early and successful 
intervention, even in relation to CADN.
20)
All of the HRV domain scores were not signifi  cantly diff  erent 
between the diabetic group and the control group. However, we 
found significant change of HRV response to deep breathing 
and standing in both groups. Generally, long expiration by 
deep breathing stimulates the PNS and results in increased HF 
score and decreased LF score.
9,21) On the other hand, standing 
stimulates SNS and results in decreased HF score and increased 
LF score. Especially, we found the change of HRV scores was 
lower in diabetic patients by augmentation with positional 
change. Th   erefore, it may be interpreted that the diabetic patients 
had lowered sympathetic responses to positional change like 
standing
20,22) and increased orthostatic hypotensive reaction.
23) 
There were several limitations in our study. Firstly, since a 
valid translation of a COMPASS questionnaire in Korean version 
had not been established, there might be a little bias due to 
cultural diff  erence. Secondly, the questions about frequency and 
severity of autonomic symptoms were composed of somewhat 
vague items. However, we provided participants with additional 
explanation for the questions to overcome the subjectivity in 
rating the severity of symptoms. Because we didn't find any 
significant difference of the total COMPASS scores between 
men and women, we didn't further analyze correlation between 
COMPASS and HRV domain score in any one gender group.
In conclusion, the COMPASS score correlated with some 
component score of the HRVin diabetics. Th   e HRV may be used 
as a tool to detect diabetic autonomic neuropathy by augmen-
tation with position change. 
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the diabetic patients were significantly prevalent compared 
with control subjects. Among nine subscales, the orthostatic 
intolerance was the most frequent symptom. As the item score 
of orthostatic intolerance was highly weighted to make a total 
COMPASS score, it may be regarded as one of important 
determining factors for the total COMPASS score. 
The COMPASS score correlated with some component 
scores of the HRV in diabetics. HRV domains related to SNS 
(normalized LF score and LF/HF ratio) correlated positively, but 
HRV domains related to PNS (normalized HF score, HF score, 
and RMSSD) did negatively with the total COMPASS score. 
Therefore, it suggests that the higher prevalence of autonomic 
symptoms in diabetic patients is, the higher activity of SNS in 
these patients is expected. Degeneration of the vagus nerve in 
an early stage
9,16) might result in relatively increased sympathetic 
activity at rest. It had been reported that high activity of SNS was 
Table 4. Difference between heart rate variability domain scores 
in supine position, in supine position with deep breathing, and on 
standing.
Variables
Diabetics 
(n = 50)
Non-diabetics 
(n = 30)
P-value*
Change from supine position to deep breathing position
∆LF (ms
2)  -47.1 (105.9) -53.5 (147.4)  0.82
∆LF (n.u.)  -33.4 (21.3)  -23.2 (20.9)  0.04
∆HF (ms
2)  104.6 (239.8)   135.7 (353.4) 0.64
∆HF (n.u)     33.4 (21.4)     23.5 (21.2)  0.04
∆LF/HF   -3.0 (4.2)  -1.8 (2.6)  0.16
∆RMSSD (ms)   -1.3 (18.2)  -1.1 (10.9) 0.94
Change from supine position to standing position
∆LF (ms
2)  -12.9 (88.8) -25.7 (117.8)  0.58
∆LF (n.u.)  7.2 (18.6)     16.6 (22.3) 0.04
∆HF (ms
2) -30.9 (124.6)  -70.3 (216.8) 0.30
∆HF (n.u)   -6.5 (17.8)  -16.1 (22.5) 0.03
∆LF/HF        0.9 (4.6)  1.0 (3.2)  0.91
∆RMSSD (ms)  -19.3 (11.7)   -4.9 (21.7)     <0.001
Values are presented as mean (SD).
LF: low frequency (0.004-0.15 Hz), n.u.: normalized units, HF: high 
frequency (0.15-0.40 Hz), LF/HF: the ratio of low to high frequency 
power, RMSSD: square root of the mean of the sum of the square of 
differences between adjacent NN interval. 
*P-value was obtained by Student’s t-test.Min-Young Chun, et al: The Association between Symptoms of Autonomic Neuropathy and the Heart Rate Variability in Diabetics
298  |  Vol. 32, No. 5 Jul 2011 Korean J Fam Med
REFERENCES
1. Aring AM, Jones DE, Falko JM. Evaluation and prevention of 
diabetic neuropathy. Am Fam Physician 2005;71:2123-8.  
2. Ewing DJ, Campbell IW, Clarke BF. Assessment of 
cardiovascular eff  ects in diabetic autonomic neuropathy and 
prognostic implications. Ann Intern Med 1980;92:308-11.  
3. Campbell IW, Ewing DJ, Clarke BF. Painful myocardial 
infarction in severe diabetic autonomic neuropathy. Acta 
Diabetol Lat 1978;15:201-4.
4. Pickup JC, Williams G. Textbook of diabetes. Oxford: 
Blackwell Science; 1991. 
5. Marchant B, Umachandran V, Stevenson R, Kopelman PG, 
Timmis AD. Silent myocardial ischemia: role of subclinical 
neuropathy in patients with and without diabetes. J Am Coll 
Cardiol 1993;22:1433-7. 
6. Low PA, Vernino S, Suarez G. Autonomic dysfunction in 
peripheral nerve disease. Muscle Nerve 2003;27:646-61.  
7. Joo NS, Park SB, Kim KM, Kim SM, Lee DJ, Kim BT. 
Changes in heart rate variability aft  er weight reduction in the 
obese.  J Korean Acad Fam Med 2005;26:693-8.
8. Choi WS, Ock SM, Kim CM, Lee BC, Jeong KS, Lee SJ. 
Eff  ects of aerobic exercise on heart rate variability (HRV). J 
Korean Acad Fam Med 2005;26:561-6.
9. Eckberg DL. Sympathovagal balance: a critical appraisal. 
Circulation 1997;96:3224-32.  
10. Low PA. Laboratory evaluation of autonomic function. In: 
Low PA, editor. Clinical autonomic disorders: evaluation and 
management. 2nd ed. Philadelphia: Lippincott  -Raven; 1997. 
p.179-208.
11. Suarez GA, Opfer-Gehrking TL, Offord KP, Atkinson EJ, 
O'Brien PC, Low PA. The Autonomic Symptom Profile: a 
new instrument to assess autonomic symptoms. Neurology 
1999;52:523-8.  
12. Benrud-Larson LM, Dewar MS, Sandroni P, Rummans TA, 
Haythornthwaite JA, Low PA. Quality of life in patients 
with postural tachycardia syndrome. Mayo Clin Proc 
2002;77:531-7.  
13. Expert Committee on the Diagnosis and Classification of 
Diabetes Mellitus. Report of the expert committee on the 
diagnosis and classification of diabetes mellitus. Diabetes 
Care 2003;26 Suppl 1:S5-20.  
14. Ziegler D, Gries FA, Spuler M, Lessmann F. The epidem-
iology of diabetic neuropathy. Diabetic Cardiovascular Auto-
nomic Neuropathy Multicenter Study Group. J Diabetes 
Compli cations 1992;6:49-57.  
15. Hosking DJ, Bennett T, Hampton JR. Diabetic autonomic 
neuropathy. Diabetes 1978;27:1043-55.  
16. Ewing DJ, Campbell IW, Clarke BF. Mortality in diabetic 
autonomic neuropathy. Lancet 1976;1:601-3.  
17. Ziegler D, Laux G, Dannehl K, Spuler M, Muhlen H, Mayer P, 
et al. Assessment of cardiovascular autonomic function: age-
related normal ranges and reproducibility of spectral analysis, 
vector analysis, and standard tests of heart rate variation and 
blood pressure responses. Diabet Med 1992;9:166-75.  
18. Schlaich MP, Kaye DM, Lambert E, Sommerville M, 
Socratous F, Esler MD. Relation between cardiac sympathetic 
activity and hypertensive left ventricular hypertrophy. 
Circulation 2003;108:560-5.  
19. Roy TM, Peterson HR, Snider HL, Cyrus J, Broadstone 
VL, Fell RD, et al. Autonomic influence on cardiovascular 
performance in diabetic subjects. Am J Med 1989;87:382-8.  
20. Schonauer M, Th   omas A, Morbach S, Niebauer J, Schonauer 
U, Thiele H. Cardiac autonomic diabetic neuropathy. Diab 
Vasc Dis Res 2008;5:336-44.  
21. Low PA, Benrud-Larson LM, Slett  en DM, Opfer-Gehrking 
TL, Weigand SD, O'Brien PC, et al. Autonomic symptoms 
and diabetic neuropathy: a population-based study. Diabetes 
Care 2004;27:2942-7.  
22. Jacob G, Atkinson D, Jordan J, Shannon JR, Furlan R, Black 
BK, et al. Eff  ects of standing on cerebrovascular resistance in 
patients with idiopathic orthostatic intolerance. Am J Med 
1999;106:59-64.  
23. Hilsted J, Parving HH, Christensen NJ, Benn J, Galbo H. 
Hemodynamics in diabetic orthostatic hypotension. J Clin 
Invest 1981;68:1427-34.